{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:47:41Z","timestamp":1767890861908,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mechanisms of Ageing and Development"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.mad.2022.111691","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T11:40:49Z","timestamp":1656589249000},"page":"111691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Blood circulating miR-28-5p and let-7d-5p associate with premature ageing in Down syndrome"],"prefix":"10.1016","volume":"206","author":[{"given":"Cristina","family":"Morsiani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Giulia","family":"Bacalini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Collura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Moreno-Villanueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolle","family":"Breusing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"B\u00fcrkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilman","family":"Grune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda","family":"De Eguileor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Capri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mad.2022.111691_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-pharmtox-041521-103641","article-title":"Prenatal and postnatal pharmacotherapy in down syndrome: the search to prevent or ameliorate neurodevelopmental and neurodegenerative disorders","volume":"62","author":"Bartesaghi","year":"2022","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"10.1016\/j.mad.2022.111691_bib2","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1021\/acs.jproteome.5b00356","article-title":"Plasma N-Glycome Signature of Down Syndrome","volume":"14","author":"Borelli","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mad.2022.111691_bib3","first-page":"11","article-title":"Down syndrome and microRNAs","volume":"8","author":"Br\u00e1s","year":"2018","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.mad.2022.111691_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jad.2012.03.037","article-title":"Cytotoxic lymphocyte microRNAs as prospective biomarkers for chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"141","author":"Brenu","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.mad.2022.111691_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mad.2015.03.006","article-title":"MARK-AGE biomarkers of ageing","volume":"151","author":"B\u00fcrkle","year":"2015","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.mad.2022.111691_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mad.2015.03.010","article-title":"MARK-AGE population: from the human model to new insights","volume":"151","author":"Capri","year":"2015","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.mad.2022.111691_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3014","article-title":"MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer\u2019s disease","volume":"20","author":"Chen","year":"2018","journal-title":"J. Gene Med."},{"key":"10.1016\/j.mad.2022.111691_bib8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.tins.2017.10.001","article-title":"Predicting Age Using Neuroimaging: Innovative Brain Ageing Biomarkers","volume":"40","author":"Cole","year":"2017","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.mad.2022.111691_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1021\/acschemneuro.9b00585","article-title":"Composite scores of plasma tau and \u03b2-amyloids correlate with dementia in down syndrome","volume":"11","author":"Fang","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.mad.2022.111691_bib10","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/S0140-6736(20)30689-9","article-title":"Clinical and biomarker changes of Alzheimer\u2019s disease in adults with Down syndrome: a cross-sectional study","volume":"395","author":"Fortea","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mad.2022.111691_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12903","article-title":"Accelerated bio-cognitive aging in Down syndrome: State of the art and possible deceleration strategies","volume":"18","author":"Franceschi","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.mad.2022.111691_bib12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jacc.2019.12.032","article-title":"The contextualized genetics of human longevity: JACC focus seminar","volume":"75","author":"Franceschi","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.mad.2022.111691_bib13","series-title":"Biochemistry and Cell Biology of Ageing: Part II Clinical Science, Subcellular Biochemistry","first-page":"161","article-title":"Down syndrome, ageing and epigenetics","author":"Gensous","year":"2019"},{"key":"10.1016\/j.mad.2022.111691_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113111","article-title":"Age-related changes of adaptive and neuropsychological features in persons with down syndrome","volume":"9","author":"Ghezzo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mad.2022.111691_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1567205012666151020114607","article-title":"Aging in down syndrome and the development of Alzheimer\u2019s disease neuropathology","volume":"13","author":"Head","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.mad.2022.111691_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/acel.12325","article-title":"Accelerated epigenetic aging in Down syndrome","volume":"14","author":"Horvath","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.mad.2022.111691_bib17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2174\/1570159X13666150928105725","article-title":"Myalgic encephalomyelitis: symptoms and biomarkers","volume":"13","author":"Jason","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.mad.2022.111691_bib18","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ajmg.b.32575","article-title":"Longitudinal telomere shortening and early Alzheimer\u2019s disease progression in adults with down syndrome","volume":"174","author":"Jenkins","year":"2017","journal-title":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics"},{"key":"10.1016\/j.mad.2022.111691_bib19","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.18632\/oncotarget.23406","article-title":"Menopause and adipose tissue: miR-19a-3p is sensitive to hormonal replacement","volume":"9","author":"Kangas","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.mad.2022.111691_bib20","doi-asserted-by":"crossref","first-page":"D239","DOI":"10.1093\/nar\/gkx1141","article-title":"DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA\u2013gene interactions","volume":"46","author":"Karagkouni","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mad.2022.111691_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cell.2014.10.039","article-title":"Geroscience: linking aging to chronic disease","volume":"159","author":"Kennedy","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.mad.2022.111691_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069807","article-title":"Circulating miRNA biomarkers for Alzheimer\u2019s disease","volume":"8","author":"Kumar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mad.2022.111691_bib23","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s43440-020-00107-0","article-title":"Clinical significance of fluid biomarkers in Alzheimer\u2019s Disease","volume":"72","author":"Lewczuk","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.mad.2022.111691_bib24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3892\/mmr.2020.11781","article-title":"Bioinformatics analysis indicates that microRNA\u2011628\u20135p overexpression may alleviate Alzheimer\u2019s disease by targeting TYROBP","volume":"23","author":"Liu","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.mad.2022.111691_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","article-title":"Dementia in down syndrome: unique insights for Alzheimer disease research","volume":"15","author":"Lott","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.mad.2022.111691_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fnagi.2019.00222","article-title":"Age-dependent relationship between plasma A\u03b240 and A\u03b242 and total tau levels in cognitively normal subjects","volume":"11","author":"Lue","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.mad.2022.111691_bib27","article-title":"miRNA expression profile and involvement of Let-7d-APP in aged rats with isoflurane-induced learning and memory impairment","volume":"10","author":"Luo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mad.2022.111691_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mad.2015.03.007","article-title":"MARK-AGE standard operating procedures (SOPs): a successful effort","volume":"151","author":"Moreno-Villanueva","year":"2015","journal-title":"Mech. Ageing Dev. Biomark. Hum. Ageing"},{"key":"10.1016\/j.mad.2022.111691_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2013.00121","article-title":"Circulating inflamma-miRs in aging and age-related diseases","volume":"4","author":"Olivieri","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.mad.2022.111691_bib30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/77153","article-title":"Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts","volume":"25","author":"Paloneva","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mad.2022.111691_bib31","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1210\/jcem.82.7.4087","article-title":"Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function","volume":"82","author":"Paolisso","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mad.2022.111691_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.14283\/jpad.2018.41","article-title":"Plasma A\u03b242\/40 ratio detects early stages of Alzheimer\u2019s disease and correlates with CSF and neuroimaging biomarkers in the AB255 study","volume":"6","author":"P\u00e9rez-Grijalba","year":"2019","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.mad.2022.111691_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12967-018-1414-x","article-title":"Association of chronic fatigue syndrome with premature telomere attrition","volume":"16","author":"Rajeevan","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.mad.2022.111691_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.792165","article-title":"DNA methylation analysis of ribosomal DNA in adults with down syndrome","volume":"13","author":"Ravaioli","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.mad.2022.111691_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jphs.2014.11.011","article-title":"The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration","volume":"127","author":"Ruscher","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.mad.2022.111691_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/apha.12819","article-title":"Striated muscle activator of Rho signalling (STARS) is reduced in ageing human skeletal muscle and targeted by miR-628-5p","volume":"220","author":"Russell","year":"2017","journal-title":"Acta Physiol."},{"key":"10.1016\/j.mad.2022.111691_bib37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10571-011-9769-z","article-title":"Gene expression profile of THP-1 monocytes following knockdown of DAP12, a causative gene for Nasu-Hakola disease","volume":"32","author":"Satoh","year":"2012","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.mad.2022.111691_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-019-0477-0","article-title":"Plasma biomarkers for amyloid, tau, and cytokines in down syndrome and sporadic Alzheimer\u2019s disease","volume":"11","author":"Startin","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.mad.2022.111691_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-1-14","article-title":"Microglia and neuroinflammation: a pathological perspective","volume":"1","author":"Streit","year":"2004","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.mad.2022.111691_bib40","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s12035-012-8359-5","article-title":"Non-coding RNAs in Alzheimer\u2019s disease","volume":"47","author":"Tan","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mad.2022.111691_bib41","first-page":"13","article-title":"Association between plasma amyloid-\u03b2 and neuropsychological performance in patients with cognitive decline","author":"Yun","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.mad.2022.111691_bib42","first-page":"13","article-title":"The role of age on beta-amyloid1\u201342 plasma levels in healthy subjects","author":"Zecca","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.mad.2022.111691_bib43","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/srep01329","article-title":"MicroRNA let-7d regulates the TLX\/microRNA-9 cascade to control neural cell fate and neurogenesis","volume":"3","author":"Zhao","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mad.2022.111691_bib44","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Mechanisms of Ageing and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637422000732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637422000732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T17:48:05Z","timestamp":1758649685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0047637422000732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":44,"alternative-id":["S0047637422000732"],"URL":"https:\/\/doi.org\/10.1016\/j.mad.2022.111691","relation":{},"ISSN":["0047-6374"],"issn-type":[{"value":"0047-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood circulating miR-28-5p and let-7d-5p associate with premature ageing in Down syndrome","name":"articletitle","label":"Article Title"},{"value":"Mechanisms of Ageing and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mad.2022.111691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111691"}}